Results
|
|
5361.
|
|
|
|
5362.
|
|
|
|
5363.
|
|
|
|
5364.
|
|
|
|
5365.
|
|
|
|
5366.
|
|
|
|
5367.
|
|
|
|
5368.
|
|
|
|
5369.
|
|
|
|
5370.
|
|
|
|
5371.
|
|
|
|
5372.
|
|
|
|
5373.
|
|
|
|
5374.
|
|
|
|
5375.
|
|
|
|
5376.
|
|
|
|
5377.
|
|
|
|
5378.
|
|
|
|
5379.
|
Characterization of haematological parameters with bortezomib-melphalan-prednisone versus melphalan-prednisone in newly diagnosed myeloma, with evaluation of long-term outcomes and risk of thromboembolic events with use of erythropoiesis-stimulating agents: analysis of the VISTA trial. [electronic resource] by
- Richardson, Paul
- Schlag, Rudolf
- Khuageva, Nuriet
- Dimopoulos, Meletios
- Shpilberg, Ofer
- Kropff, Martin
- Vekemans, Marie-Christiane
- Petrucci, Maria Teresa
- Rossiev, Viktor
- Hou, Jian
- Robak, Tadeusz
- Mateos, Maria-Victoria
- Anderson, Kenneth
- Esseltine, Dixie-Lee
- Cakana, Andrew
- Liu, Kevin
- Deraedt, William
- van de Velde, Helgi
- San Miguel, Jesús F
Producer: 20120608
In:
British journal of haematology vol. 153
Availability: No items available.
|
|
|
5380.
|
|